Colonic Tissue Expression of MAdCAM‐1 Is Not Predictive of Vedolizumab Responsiveness in Inflammatory Bowel Disease

ABSTRACT We assessed the predictive value of MAdCAM‐1 expression on response to vedolizumab in patients with inflammatory bowel disease. This was a retrospective, single‐center, cohort study including 109 patients with pretreatment inflammation who completed at least three doses of vedolizumab. We d...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Nikhil Reddy, Jeremy A. Klein, Nikita Thomas, Dejan Micic, Zifeng Deng, David T. Rubin, Russell D. Cohen, Sushila Dalal, Britt Christensen, Haider I. Haider, Vesta Valuckaite, Katherine R. Meckel, Marc Bissonnette, Christopher R. Weber, Joel Pekow
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Wiley 2025-12-01
Serie:	Clinical and Translational Science
Soggetti:	immunology inflammation molecular therapeutics monoclonal antibodies pharmacology therapeuticsgastrointestinal
Accesso online:	https://doi.org/10.1111/cts.70422
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!